2Mamidi A, De Simone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection [J]. J Neuro Virol, 2002, 8(3): 158-167.
3Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the Medicine Association/Infectious Diseases Society of America [J]. Clin Infect Dis, 2005, 40(Suppl 3): S131-235.
4Abgrall S, Rabaud C, Costagliola D, et al. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era[J]. Clin Infect Dis, 2001, 33(10): 1747-1755.
5Habegger de Sorrentino A, Lopez R, Motta P, et al. HLA class Ⅱ involvement in HIV-associated toxoplasmie encephalitis development[J]. Clin Immunol, 2005, 115(2): 133-137.
6Cinque P, Scarpellini P, Vago L, et al. Diagnosis of central nesystem complications in HIV-infected patients : cerebrospinal fluid analysis by the polymerase chain reaction[J] . AIDS, 1997, 11 (1): 1-17.
7Colombo FA, Vidal JE, Penalva de Oliveira AC, et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples[J]. J Clin Microbiol, 2005, 43(10): 5044-5047.
8Bertschy S, Opravil M, Cavassini M, et al. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy [J]. Clin Microbiol Infect, 2006, 12(7): 666-671.
9Tumwine JK, Kekitiinwa A, Bakeera-Kitaka S, et al. Cryptospofidiosis and microsporidiosis in Ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus[J]. Am J Trop Med Hyg, 2005, 73 (5) : 921-925.
10Miao YM, Awad-El-Kariem FM, Franzen C, et al. Eradication of cryptospofidia and microspofidia following successful antiretroviral therapy[J]. J AIDS, 2000, 25(2): 124-129.
7WasserSO. Medicinal mushrooms as a source of antitumor and im-munomodulating polysaccharides [J]. Appl Microbiol Biotechnol,2002,60(3):258-274.
8ennink-KerstenMA,Donnelly JP,Verweij PE. Detection of circu-lating galactomannan for the diagnosis andmanagement of invasiveaspergillosis[J]. Lancet Infect Dis, 2004,4(6) : 349-357.
9SahaDC,Xess I,Jain N. Evaluation of conventional&serologicalmethods for rapid diagnosis of cryptococcosis [J]. Indian J MedRes,2008,127(5):483-488.
10YangYL,Chen M,Gu QT,et al. Cryptococcosis in kidney trans-plant recipients in a Chinese university hospital and a review ofpublish cases[J]. Int J Infect Dis,2014,26: 154-161.
